Impact of Yo-Yo Sleep on Cardiometabolic Health
Launched by COLUMBIA UNIVERSITY · May 25, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the Clinical Trial: Impact of Yo-Yo Sleep on Cardiometabolic Health**
This clinical trial is looking at how different sleep patterns affect our health, specifically focusing on issues related to weight and metabolism, like cardiometabolic syndrome and obesity. Researchers want to see what happens when people have short sleep for five days followed by two days of longer sleep, compared to those who get enough sleep every night. They are also interested in whether sticking to a regular sleep schedule helps people feel better compared to when their sleep times are pushed back by two hours. The study will last for four weeks and is open to young and middle-aged adults between the ages of 18 and 49 who generally sleep well at night.
To join the study, participants need to be healthy adults with a body mass index (BMI) between 20 and 29.9, and they should be sleeping 7 to 9 hours each night without using sleep aids or taking naps. However, people with certain health issues, like sleep disorders or diabetes, or those who smoke, are not eligible. Participants can expect to be involved in a structured program that will help researchers gather important information about sleep and health. If you're interested in learning more or think you might qualify, this could be a great opportunity to contribute to important research while also gaining insights into your own health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 to 49 years
- • BMI 20-29.9 kg/m2
- • Habitually sleeping 7-9 hours/night without sleep aids or naps
- Exclusion Criteria:
- • Sleep disorders
- • Psychiatric disorders (including eating disorders) and seasonal affective disorder
- • Pregnancy (current/prior year)
- • Breastfeeding
- • Smokers (Any cigarette smoking or ex-smokers \<3years)
- • Diabetes
- • Elevated blood pressure, taking beta-blockers
- • Individuals taking anti-coagulants or anti-platelets
- • Recent weight change or participation in a weight loss program or have ever had bariatric surgery or other weight loss or gastrointestinal procedure.
- • Travel across time zones; shift work (non-traditional hours)
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Marie-Pierre St-Onge, PhD
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported